相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Detecting Liver Cancer Using Cell-Free DNA Fragmentomes
Zachariah H. Foda et al.
CANCER DISCOVERY (2023)
Cell-free DNA analysis in current cancer clinical trials: a review
M. Cisneros-Villanueva et al.
BRITISH JOURNAL OF CANCER (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
Ruben Van Paemel et al.
EUROPEAN JOURNAL OF CANCER (2022)
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics
Xiangyu Zhang et al.
HEPATOLOGY (2022)
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Saife N. Lone et al.
MOLECULAR CANCER (2022)
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Blanca Trujillo et al.
BRITISH JOURNAL OF CANCER (2022)
Circulating tumour DNA - looking beyond the blood
Ann Tivey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling
Wei Guo et al.
EBIOMEDICINE (2022)
Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management
Blake Salfer et al.
CLINICAL CHEMISTRY (2022)
Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA
Jonathan C. M. Wan et al.
NATURE COMMUNICATIONS (2022)
cfDNA methylome profiling for detection and subtyping of small cell lung cancers
Francesca Chemi et al.
NATURE CANCER (2022)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Usha Menon et al.
LANCET (2021)
Women's cancers in China: a spatio-temporal epidemiology analysis
Rongxin He et al.
BMC WOMENS HEALTH (2021)
A novel decision tree model based on chromosome imbalances in cell-free DNA and CA-125 in the differential diagnosis of ovarian cancer
Weina Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
Sally M. Hunter et al.
BMC RESEARCH NOTES (2020)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis
Yanting Zhang et al.
BMC CANCER (2019)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Copy number signatures and mutational processes in ovarian carcinoma
Geoff Macintyre et al.
NATURE GENETICS (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling
Youn Jin Choi et al.
JOURNAL OF PATHOLOGY (2017)
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
Jennifer Ducie et al.
NATURE COMMUNICATIONS (2017)
Variant Review with the Integrative Genomics Viewer
James T. Robinson et al.
CANCER RESEARCH (2017)
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue
Tanjina Kader et al.
GENOME MEDICINE (2016)
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma
Oumou Goundiam et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
Roland F. Schwarz et al.
PLOS MEDICINE (2015)
Phylogenetic Quantification of Intra-tumour Heterogeneity
Roland F. Schwarz et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
Simona Ferraro et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma
Chang Ohk Sung et al.
CANCER GENETICS (2013)
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
Zhigang C. Wang et al.
CLINICAL CANCER RESEARCH (2012)
Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations
Sally M. Hunter et al.
CLINICAL CANCER RESEARCH (2012)
Genomic aberrations relate early and advanced stage ovarian cancer
Afra Zaal et al.
CELLULAR ONCOLOGY (2012)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Ovarian cancer: the duplicity of CA125 measurement
Amer K. Karam et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis
Manasa Ramakrishna et al.
PLOS ONE (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Dariush Etemadmoghadam et al.
CLINICAL CANCER RESEARCH (2009)
DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification
M. E. Nowee et al.
JOURNAL OF PATHOLOGY (2007)